<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03871647</url>
  </required_header>
  <id_info>
    <org_study_id>PhD 53</org_study_id>
    <nct_id>NCT03871647</nct_id>
  </id_info>
  <brief_title>Effect of Genetic Polymorphism on the Occurrence of Post-Operative Atrial Fibrillation After CABG</brief_title>
  <official_title>Effect of Genetic Polymorphism on the Occurrence of Post-Operative Atrial Fibrillation After Coronory Artery Bypass Grafting (CABG) Surgery in Egyptian Patients Receiving Beta Blockers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Misr International University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative Atrial Fibrillation (POAF) is one of the most common complications following
      coronary artery bypass grafting (CABG) occurring to 20% - 40% of patients. It is associated
      with prolonged hospitalization, increased hospital costs, increased complications and
      mortality rate.

      Despite the use of Beta Blockers, approximately 20% of patients develop atrial fibrillation
      following CABG surgery, suggesting a role for polymorphism in the genes The aim of the
      present study is to determine the minor allele frequency of some of the genes that affect the
      beta blockers' response and to determine the association between polymorphism in these genes
      and the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting
      in Egyptian patients receiving perioperative beta blockers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2018</start_date>
  <completion_date type="Anticipated">July 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of Atrial fibrillation</measure>
    <time_frame>within 6 days after the operation</time_frame>
    <description>Atrial fibrillation based on postoperative electrocardiogram. AF diagnostic criteria will include absence of discrete P waves, the RR intervals follow unrepetitive form and the ranges of ventricular rate usually between 90 and 170 beats/min.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Bypass Graft Surgery</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>POAF group</arm_group_label>
    <description>Patients who will experience AF at any time during the first six days after the operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non POAF group</arm_group_label>
    <description>Patients with a sinus rhythm during the first six days after the operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Beta blocker</intervention_name>
    <description>perioperative beta blockers</description>
    <arm_group_label>Non POAF group</arm_group_label>
    <arm_group_label>POAF group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Egyptian patients undergoing Coronary Artery Bypass grafting Surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age above 18 years.

          2. Candidates for CABG surgery without a concurrent valve surgery.

          3. Patients receiving perioperative beta blockers before new onset of postoperative AF.

        Exclusion Criteria:

          1. Patients who have either persistent or permanent AF, atrial flutter or atrial
             tachycardia on ECG obtained on the day of the operation.

          2. Serum creatinine &gt;2 mg/dL before the surgery.

          3. Uncontrolled thyroid disease.

          4. Recent treatment with amiodarone before the occurrence of POAF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dina M El Gindy, MSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Misr Ineternational University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lamiaa M ElWakeel, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mona F Schaalan, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Misr International University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ramy MR Khorshid, Md, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams Uiversity</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed H Solayman, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Ain Sham University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dina M El Gindy, MSc</last_name>
    <phone>00201223289088</phone>
    <email>dina_kamal25@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Cardiovascular &amp; Thoracic Academy - Ain Shams University.</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramy Khorshid, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Misr International University</investigator_affiliation>
    <investigator_full_name>Dina Mohamed Kamal El gindy</investigator_full_name>
    <investigator_title>Assistant Lecturer of Clinical Pharmacy</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenergic beta-Antagonists</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

